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https://doi.org/10.1016/j.stemcr.2018.03.021SUMMARYThyroid hormone (TH) transporters are required for the transmembrane passage of TH in target cells. In humans, inactivatingmutations
in the TH transporter MCT8 cause the Allan-Herndon-Dudley syndrome, characterized by severe neuromuscular symptoms and an
abnormal TH serum profile, which is fully replicated in Mct8 knockout mice and Mct8/Oatp1c1 double-knockout (M/O DKO) mice.
Analysis of tissue TH content and expression of TH-regulated genes indicate a thyrotoxic state in Mct8-deficient skeletal muscles. Both
TH transporters are upregulated in activated satellite cells (SCs). InM/O DKO mice, we observed a strongly reduced number of differen-
tiated SCs, suggesting an impaired stem cell function. Moreover, M/O DKO mice and mice lacking both transporters exclusively in SCs
showed impaired skeletalmuscle regeneration. Our data provide solid evidence for a unique gate-keeper function ofMCT8 andOATP1C1
in SC activation, underscoring the importance of a finely tuned TH signaling during myogenesis.INTRODUCTION
Cellular entry and efflux of thyroid hormones (THs)
are facilitated by transmembrane transporters such as
the monocarboxylate transporters 8 (MCT8) and 10
(MCT10), organic anion transporting protein 1C1
(OATP1C1), and the L-type amino acid transporters LAT1
and LAT2 (Bernal et al., 2015; Heuer and Visser, 2009,
2013). MCT8, the most intensively studied TH transporter,
is encoded by the SLC16A2 gene and exhibits the highest
specificity toward the prohormone 3,30,5,50-tetraiodothyr-
onine (thyroxine; T4) and the active form 3,30,5-triiodo-
thyronine (T3) (Friesema et al., 2003, 2005; Visser et al.,
2011). Inactivating mutations in MCT8 were identified to
underlie the clinical picture of the Allan-Herndon-Dudley
syndrome (AHDS), a severe form of psychomotor retarda-
tion (Dumitrescu et al., 2004; Friesema et al., 2004;
Schwartz et al., 2005). As a hallmark of this disease, patients
present characteristic alterations in the serum TH profile
with highly elevated T3 and decreased T4 concentrations
along with signs of a peripheral thyrotoxicity such as hy-
permetabolism, low body weight, and muscle wasting.
Moreover, affected patients suffer from pronounced neuro-
muscular abnormalities and uncontrolled motor move-
ments (Dumitrescu et al., 2004; Schwartz et al., 2005).
In order to gain insights into the pathogenic mecha-
nisms of AHDS, Mct8 knockout (KO) mice were generated
(Dumitrescu et al., 2006; Trajkovic et al., 2007; WirthS
This is an open access article under the Cet al., 2009). Though these Mct8 KO mice fully replicate
the abnormal serum TH profile and the peripheral hyper-
thyroidism of AHDS patients, they do not show any neuro-
logical impairment or behavioral abnormalities (Ceballos
et al., 2009; Trajkovic et al., 2007). Indeed, we recently
demonstrated that, in mice, only the concomitant inacti-
vation of two TH transporters, MCT8 and OATP1C1 (en-
coded by the Slco1c1 gene), results in a strongly diminished
transport of TH across the blood-brain barrier (BBB) and,
consequently, in highly reduced TH concentrations within
theCNS (Mayerl et al., 2014). Since, in rodents, OATP1C1 is
strongly expressed in brain endothelial cells but absent in
endothelial cells of the primate CNS (Ito et al., 2011; Rob-
erts et al., 2008), it has been postulated that OATP1C1
can compensate for the loss of MCT8 at the BBB in mice
but not in humans.
Despite their central state of TH deprivation, Mct8/
Oatp1c1 double-knockout (M/O DKO) mice show a similar
state of peripheral hyperthyroidism as Mct8 KO mice.
Moreover, unlike the single-mutant animals, only M/O
DKO mice exhibit pronounced behavioral alterations
including an ataxic gait and reduced locomotor perfor-
mance making it a suitable model for AHDS (Mayerl
et al., 2014).
Skeletal muscle is a major target of TH signaling, and
changes in TH homeostasis are often linked to myopathic
symptoms (Lee et al., 2014; Salvatore et al., 2014). Among
those factors that are transcriptionally regulated by TH aretem Cell Reports j Vol. 10 j 1–16 j June 5, 2018 j ª 2018 The Author(s). 1
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chain (MHC) type I (MHCI),MHCIIa,MHCIIb, andMHCIIx,
and the transcription factors MYOD and MYOGENIN,
which are essential for myogenesis and regeneration. The
latter represents a highly orchestrated process that is trig-
gered upon muscle injury and involves the activation of
quiescent muscle stem cells (satellite cells [SCs]) followed
by proliferation of myoblasts, their differentiation into
myocytes, terminal fusion into myotubes, and the final
maturation of newly formed myofibers (Bentzinger et al.,
2012).
Here, we elucidate SC function and regenerative capacity
inMct8/Oatp1c1-deficient mice. We demonstrate that both
TH transporters become upregulated in activated SCs and
that a combinedMct8/Oatp1c1 deficiency results in impair-
ments in SC differentiation, thereby leading to a delayed
skeletal muscle regeneration. Therefore, our study is the
first that demonstrates a gate-keeper function of TH trans-
porters within the precisely coordinated progression of SC
activation and the differentiation program.RESULTS
Thyroidal State of Skeletal Muscles
Mct8 deficiency in male mice leads to highly elevated
serum T3 concentrations and rather low serum T4 levels
while inactivation of Oatp1c1 in male mice does not affect
serum TH concentrations (Dumitrescu et al., 2006; Mayerl
et al., 2012; Trajkovic et al., 2007). In order to rule out any
sex-specific differences in TH status, we now also deter-
mined serum TH concentrations in 4-month-old female
TH transporter mutants and found similar TH values indi-
cating that Mct8 deficiency in females fully replicates the
TH abnormalities described in males (Figure 1A). Determi-
nation of tissue TH content in tibialis anterior (TA) muscle
preparations from these mice revealed normal T3 and T4
values in Oatp1c1 KO mice (Figure 1B), whereas the T3
content was found to be 3.5-fold elevated in Mct8 KO and
M/O DKO animals. Interestingly, Mct8 KO mice showed
normal tissue T4 values in TAmuscle preparations, whereas
the muscle T4 concentrations of M/O DKO mice were
significantly decreased.
Local tissue TH concentrations are strongly influenced by
the activities of TH metabolizing iodothyronine deiodi-
nases type 2 (D2) and type 3 (D3), which can activate and
inactivate TH by outer-ring and inner-ring deiodination,
respectively (Bianco et al., 2002). Compared with control
animals, Mct8 KO mice exhibited a 3-fold increase in
muscle D2 activities, while D3 values were not altered (Fig-
ure 1C). Remarkably, M/O DKO animals showed even a
6-fold rise in D2 activities, which might explain the drop
in muscle T4 content in these animals. Concomitantly,2 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018D3 activities were significantly elevated in M/O DKO mice
compared with respective levels in wild-type (WT) and
Mct8 KO animals, and a trend toward higher D3 activities
was also observed in Oatp1c1 KO mice. These findings
point to distinct changes in skeletal muscle TH homeosta-
sis in the absence of MCT8 and OATP1C1.
To investigate the functional consequences of this per-
turbed TH homeostasis in skeletal muscle we performed
real-time qPCR (qPCR) analysis of TA muscle samples (Fig-
ure 1D).D2mRNA levels were largely in line with the enzy-
matic activities, whereas D3 transcript levels were close to
the detection limit and therefore did not reveal any signif-
icant alterations. Expression of Hairless, a gene positively
regulated by TH, was strongly increased in Mct8 KO and
M/O DKO mice (Di Cosmo et al., 2013), while mRNA
expression of MhcI, which is negatively regulated by TH
(Soukup and Smerdu, 2015), was suppressed in Mct8-defi-
cient mice. Likewise, transcript levels of MhcIIa, MhcIIb,
and MhcIIx, known to be stimulated by TH (Soukup and
Smerdu, 2015), tended to be elevated in Mct8 KO and
M/O DKO mice. Together, these results are indicative of a
hyperthyroid state of skeletal muscle in the absence of
MCT8, and MCT8 and OATP1C1. Importantly, MyoD1
mRNA levels, a marker for activated SCs, did not show a
rise in muscle tissue of Mct8 KO and M/O DKO mice, sug-
gesting that the changes in TH homeostasis did not lead
to activation of SCs, which would be indicative of a pheno-
type resembling muscular dystrophy (Chang et al., 2016).
Next, we investigated muscle fiber type composition
using antibodies recognizing either MHCI (slow MHC)
only or all fast MHC isoforms (MHCIIa, IIb, and IIx). We
found a reduction in the percentage of muscle fibers
expressing slow MHC as well as an increase in the percent-
age of muscle fibers expressing fast MHC isoforms in Mct8
KO andM/ODKOmice. Importantly, we found this shift in
fiber types both in the soleus muscle (Figure 2A) and in the
plantaris muscle (Figure 2B), the former consisting of
primarily slow fibers, while the latter comprises mostly
faster muscle fibers. These findings prompted us to subse-
quently clarify the cellular distribution of MCT8 and
OATP1C1 in muscle tissue.
MCT8 and OATP1C1 Show Distinct Expression
Patterns during Myogenesis
To obtain a broad overview of the expression pattern of
different TH hormone transporters (Bernal et al., 2015)
during myogenesis, we took advantage of our previously
published Affymetrix microarray gene expression analysis
(Price et al., 2014). Thereby, we compared freshly isolated
(quiescent) SCs, SC-derived myoblasts, and differentiating
myotubes (Figure 3A). Interestingly, Mct8 as well as Mct10
showed highest signal intensities in quiescent SCs. High
transcript levels were also found for the L-type amino
Figure 1. Thyroid State of Skeletal Mus-
cle in TH Transporter-Deficient Mice
(A) Measuring serum TH concentrations in
4-month-old female mice (n = 8) revealed
highly elevated serum T3 and decreased
serum T4 values in Mct8 deficiency, thereby
replicating the characteristic TH serum
profile of male Mct8 KO animals.
(B) TA muscle T3 content was almost 4-fold
elevated in Mct8 KO and M/O DKO mice,
while muscle T4 levels were reduced in M/O
DKO mice only (n = 4 Mct8 KO; n = 5 WT,
Oatp1c1 KO, M/O DKO mice).
(C) D2 and D3 enzymatic activities were
measured in TA muscle homogenates. M/O
DKO mice showed a pronounced rise in D2
and D3 activities (n = 6).
(D) qPCR analyses were performed using TA
muscle homogenates from 2- to 3-month-
old female mice to assess transcript levels of
TH-regulated genes.
Group means + SEM are shown. n = 3 Mct8
KO; M/O DKO; n = 5 WT, Oatp1c1 KO mice.
*p < 0.05; **p < 0.01; ***p < 0.001. Two-
way ANOVA and Bonferroni-Holm post hoc
testing.
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Figure 2. Analysis of Muscle Fiber Type
Composition in TH Transporter-Deficient
Mice
(A) Soleus cryosections were immuno-
stained to visualize slow MHC or all fast MHC
isoforms (in green) and co-labeled with an
anti-LAMININ antibody (in red) to visualize
myofiber boundaries; nuclei stained in blue.
Quantification revealed a reduced percent-
age of slow MHC-positive fibers and a
concomitant increase in the percentage of
fast MHC-positive fibers in the absence of
MCT8, and MCT8 and OATP1C1.
(B) Plantaris cryosections were immuno-
stained to visualize slow MHC or all fast MHC
isoforms (in green) and co-labeled with an
anti-LAMININ antibody (in red); nuclei
stained in blue. Similar trends could be
observed.
Group means + SEM are shown. n = 3 Mct8
KO, Oatp1c1ko; n = 6 WT, M/O DKO mice.
**p < 0.01; ***p < 0.001. Two-way ANOVA
and Bonferroni-Holm post hoc testing.
Scale bar: 500 mm.
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in all myogenic cell types, while Lat2 (Slc7a8) and Oatp1c1
mRNA expressionwere rather low in all cell types analyzed.
Unfortunately, our array analysis did not provide any
information about the expression profile of genes present
in activated SCs. We therefore isolated primary extensor
digitorum longus (EDL) myofibers with their adjacent SCs
from 4-month-old female WT mice and analyzed expres-
sion of MCT8 and OATP1C1 in quiescent (0 hr), activated
(42 hr), and differentiated (72 hr) SCs by immunocyto-
chemistry (Figure 3B). The specificities of the immunofluo-4 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018rescence signals were confirmed by concomitant process-
ing and staining of EDL myofibers from M/O DKO mice
that were devoid of any specific labeling (data not shown).
Immediately after the isolation of WT fibers, faint MCT8
staining was observed in PAX7-positive, still quiescent
SCs, whereasOATP1C1-specific stainingwas not detectable
(Figure 3B). Intriguingly, with increasing time in culture
leading to activation, proliferation, and differentiation of
SCs, expression of both TH transporters became visible in
PAX7-positive cells, indicating that MCT8 and OATP1C1
expression is strongly upregulated in activated SCs.
Figure 3. TH Transporter Expression in SCs
(A) Fold changes based on log2-transformed RNA values from quiescent SCs, cultured myoblasts, myocytes, and myotubes were used to
generate global ratio heat maps. While Lat1 is highly expressed in all cell types, Mct8 and Mct10 exhibit strongest expression in SCs.
Oatp1c1 and Lat2 mRNA levels are low compared with Mct8.
(B) Primary EDL myofibers isolated from female WT mice and cultured for 0, 42, or 72 hr.
Immunofluorescence studies revealed MCT8 expression (in green, arrow) in PAX7-positive (red) SCs at all analyzed time points. In
comparison, OATP1C1 (in green, arrow) could not be detected at 0 hr but was clearly visible after 42 and 72 hr in PAX7-positive (in red) SCs.
Nuclei stained in blue. Representative images of n = 3. Scale bar: 5 mm.
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within themyogenic program (Dentice et al., 2013). There-
fore, we wondered whether the absence of MCT8 and/or
OATP1C1might interfere with the activation and differen-
tiation of SCs. Hence, EDL myofibers were isolated from
WT and TH transporter-deficient, 4-month-old female
mice and analyzed directly or after 72 hr in culture. Stain-
ing for the SC marker PAX7 and the differentiation marker
MYOD demonstrated no aberrant activation of SCs under
resting conditions in TH transporter-deficient mice (Fig-
ure 4A). Though the overall percentage of PAX7-positive
cells per cluster was comparable between the genotypes
after 72 hr in culture (Figure S1A), differences in their
differentiation state became apparent: the percentage of
non-differentiated SCs expressing only PAX7, but not
MYOD, per cluster was almost doubled in EDL cultures of
Mct8/Oatp1c1 DKO mice (Figure 4B), whereas the percent-
age of committed SCs (PAX7/MYOD double-positive) was
reduced by 47% (Figure 4C), suggesting a delay in differen-
tiation of SCs. In addition, the overall percentage of
MYOD-expressing cells per cluster was significantly
decreased in MCT8 and OATP1C1 deficiency (Figure 4D),
but not the percentage of only MYOD-positive myoblasts
(Figure S1B). Obviously, a combined MCT8 and OATP1C1
inactivation compromises directly and/or indirectly SC
differentiation in vitro.
As an additional in vitro approach to clarify the muscle-
specific function of MCT8 and OATP1C1 and to avoid
possible compensatory effects, we prepared EDL fiber
cultures fromWTand Oatp1c1 KO mice that show normal
serum TH values and a normal muscle TH content. These
fiber cultures were treated for 72 hr with Silychristin
(25 mM) as this compound has been recently shown to
specifically inhibit Mct8 (Johannes et al., 2016). Immu-
nostaining of fiber cultures with PAX7 and MYOD indeed
revealed the highest number of cells expressing only
PAX7 in Oatp1c1 KO mice treated with Silychristin (Fig-
ure 4E), whereas the percentage of PAX7-positive cells
per cluster was not altered (Figure S1C). Likewise, the
percentage of PAX7/MYOD-positive, differentiated SCs
was slightly reduced in Silychristin-treated cultures (Fig-
ure 4F), though neither the percentage of MYOD-express-
ing cells nor the percentage of MYOD only-positive
nuclei were significantly affected by the inhibitor treat-
ment (Figures 4G and S1D). Altogether, these in vitro
data suggest an impaired differentiation of SCs entering
the myogenic program in the absence of MCT8 and
OATP1C1.
Muscle Regeneration and SC Differentiation Are
Impaired In Vivo in TH Transporter-Deficient Mice
We wondered whether impairments in the myogenic
program also occur in vivo after injury when both TH trans-6 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018porters are absent. Therefore, we injured the TA muscle of
adult female mice by injection of cardiotoxin (CTX).
First, we investigated myofiber size in resting conditions
but did not observe significant differences between the
genotypes by analyzing the minimal fiber feret (diameter)
as a measure of fiber size (Figures 5A and 5B). Intriguingly,
5 days after CTX injection (5 days post injury [dpi]), the
minimal fiber feret was reduced in all TH transporter-defi-
cient animals, with the most pronounced and statistically
significant reduction inM/ODKOmice (14.4 mmcompared
with 20.5 mm in WT animals). This impaired regeneration
was still evident at 10 dpi when fiber size was still clearly
reduced in all TH transporter KO mice, with lowest values
in M/O DKO animals (19.7 mm compared with 25.2 mm in
WT controls). Interestingly, we did not observe significant
differences in myofiber size at 21 dpi, suggesting rather a
delay in regeneration than a general inhibition in the
absence of MCT8 and OATP1C1.
Since regeneration of skeletal muscle depends on func-
tional SCs (Lepper et al., 2011; Murphy et al., 2011; von
Maltzahn et al., 2013), we speculated that the delayed
regeneration ofM/O DKOmice is due to impaired SC func-
tion. Therefore, we enumerated the number of SCs express-
ing PAX7 and SCs that also express the differentiation
marker MYOD at different time points after injury as well
as under resting conditions (Figure 6A). Surprisingly,
already under resting conditions we found a 2.1-fold in-
crease in the number of PAX7-positive SCs in M/O DKO
mice, suggesting alterations in apoptosis and/or prolifera-
tion of SCs in the absence of both TH transporters (Fig-
ure 6B). Quantification of proliferating KI67-positive cells,
however, revealed similar numbers under basal conditions
in all TA sections, arguing against pronounced alterations
in SC proliferation inMct8/Oatp1c1 deficiency (Figure 6C).
Likewise, counting of PAX7/TUNEL double-positive cells
did not show any significant differences between the
genotypes as the number of apoptotic PAX7 cells were, as
expected, in general very low under basal conditions (Fig-
ure 6D). Thus, we exclude differences in proliferation or
apoptosis as the cause for the elevated numbers of SCs in
MCT8- and OATP1C1-deficient muscles.
Quantification of PAX7-positive cells at 5 dpi demon-
strated decreased numbers inMct8-deficientmuscles, while
Oatp1c1 and M/O DKO muscles did not show significant
differences compared with control mice (Figure 6E), in
the latter case possibly due to the higher number of SCs
under resting conditions. Importantly, we observed signif-
icantly reduced numbers of PAX7/MYOD-positive SCs 5
dpi in Mct8 KO and M/O DKO muscles, suggesting impair-
ments in either activation or differentiation. This promp-
ted us to quantify PAX7- and MYOD-positive cells at later
time points (10 dpi and 21 dpi). Notably, we found reduced
numbers of PAX7/MYOD double-positive cells at 10 dpi in
Figure 4. SC Activation and Differentiation Is Delayed in Myofiber Cultures of M/O DKO Mice
(A) WT, Mct8-, and/or Oatp1c1-deficient primary EDL myofibers (n = 3) were either fixed directly (0 hr) or cultured for 72 hr and incubated
with antibodies against PAX7 (in red) and the activation and differentiation marker MYOD (green) as well as with Hoechst33528 to label
cell nuclei (in blue). MYOD immunoreactivity was only detected after 72 hr of culture as expected.
(B) Marker-positive cell nuclei were quantified and revealed a higher percentage of PAX7 only immunopositive nuclei in M/O deficiency at
72 hr.
(C–D) Both the percentage of PAX7/MYOD double-positive (C) and total MYOD-positive (D) nuclei per cluster were reduced in cultures
derived from M/O DKO mice.
(E–G) EDL myofibers from WT (n = 4) and Oatp1c1 KO mice (n = 6) were cultured for 72 hr with the MCT8 inhibitor Silychristin or DMSO.
Analysis of PAX7- and MYOD-immunopositive cells demonstrated a tendency toward a higher number of PAX7+ only cells (E) and a reduced
number of PAX7/MYOD-immunopositive cells (F), but not toward total MYOD-positive cell numbers (G) in Silychristin-treated Oatp1c1-
deficient myofibers. These findings support a delayed SC activation and differentiation if OATP1C1 and MCT8 are absent or inhibited. Group
means + SEM are shown.
*p < 0.05; **p < 0.01; ***p < 0.001. Two-way ANOVA and Bonferroni-Holm post hoc testing. Scale bar: 10 mm.
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Figure 5. Compromised Muscle Regener-
ation in M/O DKO Mice
(A) The TA muscle of female mice was
injured with CTX at the age of 2.5–4 months
and mice were sacrificed 5, 10, or 21 dpi. TA
cryosections were incubated with an anti-
LAMININ antibody (in red) to visualize
myofiber boundaries and Hoechst 33258 (in
blue).
(B) No differences in myofiber size were
found in TH transporter mutant animals
under basal condition. Upon injury (5 and
10 dpi), Oatp1c1 KO, Mct8 KO, and M/O DKO
mice presented reduced myofiber diameters
with smallest fibers in M/O DKO animals. At
21 dpi, minimal fiber feret was similar in all
animal groups, indicating that, in the
absence of Mct8 and/or Oatp1c1, muscle
fiber regeneration is only temporarily de-
layed.
Group means + SEM are shown. n = 4 WT 5
dpi, M/O DKO 5 dpi; n = 3 all other groups.
**p < 0.01. Two-way ANOVA and Bonfer-
roni-Holm post hoc testing. Scale bar:
50 mm.
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not significantly altered at 10 dpi or 21 dpi (Figures 6E and
6F), suggesting inhibition of the differentiation process.
One may speculate that the abnormal serum profile and,
consequently, the global changes in muscle TH content
contribute to the delayed regenerative capacity in Mct8-
deficient animals. To exclude any systemic effects due to
the global loss of Mct8 and/or Oatp1c1, we generated
mice with a specific inducible deletion of both TH trans-
porters in SCs (Figure S2A).
For that purpose, we obtained conditional Mct8 mouse
mutants from the KOMP (Knockout Mouse Project) repos-
itory that carry loxP sites flanking exon 3 of the murine
Mct8 gene (Figure S2A). Cre recombinase-mediated
deletion of exon 3 was predicted to result in a frameshift
mutation from exon 4 to 5 and thus loss of function of
the Mct8 gene product. Mct8 fl/fl or Mct8 fl/y mice were8 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018mated with Oatp1c1 fl/f (Mayerl et al., 2012) mice and
mice carrying the Pax7 CreERT2 transgene (Murphy
et al., 2011). CRE recombinase activity was induced prior
to all experiments by tamoxifen. The successful removal
of both Mct8 exon 3 and Oatp1c1 exon 3 was confirmed
on DNA level (Figure S2B). To further prove that our
cell-specific KO strategy was successful, we isolated EDL
muscle fibers from M/O-SC KO animals and analyzed
MCT8 and OATP1C1 expression by immunostaining after
72 hr of culture. TH transporter-specific fluorescent signals
were absent in 70% of PAX7-positive cell clusters (Figures
7A, 7B, and S2C), suggesting that Cre recombinase-medi-
ated inactivation of Mct8 and Oatp1c1 was not complete
but was efficient enough for further analysis. As expected,
M/O-SC KO mice were phenotypically indistinguishable
from control animals and exhibited normal serum TH
parameters (Figure S2D).
Figure 6. Delayed SC Activation and Differentiation in M/O DKO Mice upon Injury
(A) The TA muscle of female mice was injured with CTX at the age of 2.5–4 months and mice were sacrificed 5, 10, or 21 dpi. TA sections
were stained for the SC marker PAX7 (in red), the early differentiation factor MYOD (in green), and Hoechst 33258 (in blue). Representative
images for WT and M/O DKO mice are depicted.
(legend continued on next page)
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KO mice and analyzed muscle regeneration at 10 dpi.
Importantly, we did not observe differences in SC numbers
under resting conditions between M/O-SC KO and control
mice (Figure S2E). After injury, we found a significant
decrease in the number of PAX7/MYOD double-positive
SCs (Figures 7C and 7D) and myofiber size (Figures 7E
and 7F) resembling the phenotype of M/O DKO mice.
This prompted us to conclude that MCT8 and OATP1C1
fulfill SC-specific functions during regeneration.
DISCUSSION
Skeletal muscle is a well-established TH target tissue as TH
regulates the expression of numerous muscle proteins
critical for proper muscle development and contractility
(Ambrosio et al., 2017; Milanesi et al., 2016, 2017; Soukup
and Smerdu, 2015). Thus, highly elevated serum T3 levels,
as detected in AHDS patients, are expected to heavily affect
skeletal muscle homeostasis and regeneration. Elevated T3
levels may even cause or contribute to the overt muscle
wasting and locomotor deficits of these patients. Indeed,
increased serumconcentrations of lactic acid and ammone-
mia as markers of skeletal muscle catabolism are indicative
for a thyrotoxic state of skeletal muscle tissues in those pa-
tients (Herzovich et al., 2007). Likewise, Mct8 KO mice as
well asM/O DKOmice, which both replicate the abnormal
circulating TH concentrations of the patients (Dumitrescu
et al., 2006; Mayerl et al., 2014; Trajkovic et al., 2007) (Fig-
ure 1A), show an almost 4-fold increase in TA muscle T3
content (Figure 1B). This rise in T3 is accompanied by an
increased expression of the T3-regulated target gene hair-
less. Furthermore, expression analysis of differentMHC iso-
forms and analysis of the fiber type distribution in different
skeletal muscles (Figures 1D and 2) indicate a shift from
slow-twitch to fast-twitch fibers as expected from a hyper-
thyroid muscle tissue (Figure 2) (Soukup and Smerdu,
2015). These observations are in line with previous data
describing increased skeletal muscle T3 content and TH
action in Mct8 KO mice (Di Cosmo et al., 2013).
Onemight even suggest thatMCT8 does not play amajor
role in muscle TH transport as the circulating T3 levels(B) Quantification of marker analyses in the uninjured state revealed
animals.
(C–D) However, this increase is neither due to increased proliferation
staining of PAX7-positive nuclei (D) did not reveal any significant ch
(E) Upon injury the number of PAX7-positive SCs was decreased inMct8
similar numbers.
(F) Enumeration of PAX7/MYOD double-positive cells revealed reduce
significant drop in PAX7/MYOD-positive cells was only found in M/O
Group means + SEM are shown. n = 4 WT 5 dpi, M/O DKO 5 dpi; n = 3
**p < 0.01; ***p < 0.001. Two-way ANOVA and Bonferroni-Holm pos
10 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018appear to be fully sensed byMCT8-deficient skeletalmuscle
cells. Of note, Mct10, a close relative of Mct8 and a potent
T3 transporter (Friesema et al., 2008), shows a similar skel-
etal muscle expression pattern as Mct8 according to our
cell-specific RNA profiling (Figure 3A). Thus, as also sug-
gested by Di Cosmo et al. (2013), MCT10 might at least
partially compensate for the absence of MCT8 in the
murinemuscle. Such a scenario could be tested by assessing
the thyroidal skeletal muscle phenotype of Mct10/Mct8
DKO mice, particularly as studies of double-mutant ani-
mals have already shown a concerted action of MCT10
and MCT8 in mediating TH transport in liver, kidneys,
and the thyroid (Mu¨ller et al., 2014). However, it also
should be kept in mind that muscle tissue contains various
cell types with distinct TH transporter repertoire. Thus, the
cell-specific TH status may vary greatly between different
skeletal muscle cell types in mice that lack Mct8 globally.
That this is indeed the case becomes already evident with
the determination of T4 concentrations and deiodinase ac-
tivities in skeletal muscle homogenates. Despite the low T4
levels in the circulation, skeletal muscle T4 content was
found to be surprisingly normal in Mct8 KO mice. The
observed increased mRNA levels and activities of the TH-
activating enzymeD2would be indicative of a hypothyroid
state, although the total tissue T3 content and our qPCR
data argue for a thyrotoxic situation in TA muscle (Figures
1B–1D). A different situation was found in M/O DKO
mice that displayed reduced T4 muscle content in combi-
nation with highly elevated D2 and increased activities of
the TH-inactivating enzyme D3 (Figure 1C). A simulta-
neous rise in D2 and D3 activities is contradictory to gen-
eral expectations as D2 is negatively and D3 is positively
regulated by TH (Bianco et al., 2002). Rather, our observa-
tions point to muscle-intrinsic, cell-specific changes in
TH homeostasis in Mct8 KO or M/O DKO muscles, with
some cells being in a hyperthyroid and others in a hypo-
thyroid state. As another explanation, M/O DKO mice pre-
sent a more than 2-fold increase in the number of SCs at
baseline, which are the main cellular source of D3 expres-
sion in skeletal muscle (Dentice et al., 2014). Hence, the
high D3 activities in those animals might simply reflect
the increased number of D3-expressing cells in vivo.a significantly increased number of PAX7-positive cells in M/O DKO
nor decreased apoptosis of SCs as both KI67 staining (C) and TUNEL
anges between the genotypes.
KO mice at 5 dpi, while at 10 and 21 dpi the different groups showed
d numbers in Mct8 KO and M/O DKO animals at 5 dpi. At 10 dpi, a
DKO mice.
all other groups.
t hoc testing. Scale bar: 50 mm.
Figure 7. Compromised Muscle Regeneration upon Conditional Inactivation of Mct8 and Oatp1c1 in SCs. EDL Myofibers Were
Isolated from Tamoxifen-Treated Control and M/O-SC KO Littermates and Cultured for 72 hr
(A and B) Immunofluorescence staining for MCT8 (in green) (A) and OATP1C1 (in green) (B) demonstrated signals in clusters of PAX7-
positive cells (red) in control samples, whereas signal intensities were strongly reduced in M/O-SC KO animals (nuclei in blue). Arrows
depict cells positive for PAX7 and MCT8 or PAX7 and OATP1C1, respectively.
(C) TA muscles of 3-month-old control and M/O-SC KO mice were injured with CTX and analyzed by immunostainings 10 dpi (PAX7 in red;
MYOD in green, nuclei in blue).
(D) Quantification showed a significantly reduced number of PAX7/MYOD double-positive SCs in M/O-SC KO mice.
(E) Immunofluorescence staining for LAMININ (in red) and cell nuclei (in blue) indicated similar fiber diameters in TA muscles in the
uninjured state, while M/O-SC KO animals showed a reduced myofiber size at 10 dpi.
(F) Minimal fiber feret determination in uninjured TA muscle revealed similar numbers. However, injured TA muscles of M/O-SC KO mice
revealed a reduced myofiber diameter 10 dpi. Group means + SEM are shown. n = 4.
*p < 0.05, unpaired 2-tailed Student’s t test. Scale bars: 5 mm (A and B) and 50 mm (C and E).
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tions of MCT8 and OATP1C1 we determined the cell-
type-specific expression patterns of these two transporters.
It has already been reported that Mct8 transcripts are pre-
sent in skeletal muscle tissue (Di Cosmo et al., 2013), and
our cell-type-specific profiling as well as immunohisto-
chemical data are in line with this earlier report. Intrigu-
ingly, we could detect strongest MCT8 expression in
quiescent and activated SCs, whereas OATP1C1 protein
expression was only transiently observed in activated SCs
(Figure 3). This temporally regulated expression pattern
indeed suggested a specific function of both transporters
in SCs that are required for regeneration of skeletal muscle
(Lepper et al., 2011; Murphy et al., 2011; von Maltzahn
et al., 2013).
TH tightly regulates muscle regeneration as unambigu-
ously demonstrated in various studies (Dentice et al.,
2010, 2013, 2014; Lee et al., 2014; Salvatore et al., 2014).
According to the current model, high expression of the
inactivating enzyme D3 ensures strongly reduced intracel-
lular TH levels in SCs in order to keep them in a prolifer-
ative state (Figure S3). Low intracellular TH concentrations
seem to be a prerequisite for SC proliferation and survival.
Indeed, Dentice et al. (2014) elegantly demonstrated that
D3 acts a ‘‘survival factor’’ in these cells as inactivation
of this enzyme specifically in SCs leads to caspase3-depen-
dent apoptosis of activated stem cells. Absence of MCT8
and OATP1C1 in SCs possibly results in impaired TH
uptake into these cells, thereby evoking low intracellular
TH concentrations, which in turn keeps the SCs for a
prolonged period in a proliferating state. Such a scenario
would also explain the elevated number of PAX7-positive
cells as well as the elevated D3 activities found in
M/O-deficient muscle under resting conditions in vivo
(Figure 6B).
Upon injury, SCs become activated, enter the cell cycle,
and either divide symmetrically, thereby maintaining the
pool of SCs, or asymmetrically to give rise to myogenic
progenitor cells (Bentzinger et al., 2013a). Once activated,
PAX7-positive SCs express the transcription factor MYOD,
a master regulator of myogenesis that in turn regulates
expression of downstream myogenic factors important
for proper myogenesis (Bentzinger et al., 2012; von Malt-
zahn et al., 2012). Interestingly, upregulation of MyoD
expression is controlled by local TH signaling via
numerous pathways of which T3-stimulated Foxo3 expres-
sion and, consecutively, Foxo3-induced D2 expression
represents one important mechanism (Dentice et al.,
2010). Elevated D2 activities in turn locally generate
‘‘supraphysiological’’ T3 concentrations that are needed
for robust induction of MyoD expression and thereby
trigger the differentiation process (Figure S3). Indeed,
inactivation of D2 in mice has been shown to cause12 Stem Cell Reports j Vol. 10 j 1–16 j June 5, 2018impaired differentiation of myoblasts similar to the
phenotype described for MyoD/Myf5-deficient mice (Rud-
nicki et al., 1993). Thus, adequate and precise regulation
of intracellular TH concentrations with low T3 levels
in proliferating cells and a high-T3 condition in differen-
tiating cells appears to be mandatory for proper
myogenesis.
The strictly regulated TH action during myogenesis is
obviously disturbed if Mct8 and Oatp1c1 are missing.
Myofibers prepared from M/O DKO mice and cultured
for 72 hr contained far fewer differentiated PAX7/
MYOD double-positive and MYOD-positive cells, indi-
cating that the differentiation process of PAX7-positive
SCs is compromised (Figures 4C and 4D). Accordingly,
an almost 50% reduction in Pax7/MYOD-positive cells
was detected in muscles derived from M/O DKO mice
when analyzed at 10 dpi. A significant drop in PAX7/
MYOD cells after injury was even found in M/O-SC mice
in which Mct8 and Oatp1c1 were exclusively deleted in
Pax7-positive SCs (Figure 7C). Overall, these findings
firmly demonstrate a critical cell-intrinsic role of MCT8
and OATP1C1 in SCs allowing proper timing of the differ-
entiation process only in the presence of both trans-
porters (Figure S3).
Are Mct8/Oatp1c1-deficient muscles able to fully regen-
erate in response to injury? Our in vivo studies indicate
that the regeneration process is only transiently blocked
if Mct8 and Oatp1c1 are absent. Myofiber size was tempo-
rarily reduced in TH transporter-deficient animals 5 and
10 dpi, but ultimately muscles fully regenerated to a
normal size at 21 dpi with similar numbers of SCs (Fig-
ure 4). Possibly, elevated muscle T3 content together
with the presence of other TH transporters such as
MCT10 can partially compensate for a diminished cellular
T3 transport caused by the absence of MCT8. In addition,
and similarly to the situation in the brain (Bernal et al.,
2015), the rise in muscle D2 activities in Mct8-deficient
animals might provide another compensatory mecha-
nism to counteract the compromised cellular T3 uptake.
However, such a mechanism can only provide full
compensation if sufficient amounts of T4 are available
for local T3 production. Consequently, a combined dele-
tion of Mct8 and Oatp1c1 that putatively compromises
both T4 and T3 uptake into SCs affects proper SC differen-
tiation to a much greater extent than inactivation of Mct8
alone.
Overall, our data provide solid evidence for a unique
gate-keeper function of MCT8 and OATP1C1 in SC activa-
tion and underscore the importance of a finely tuned TH
signaling within the myogenic program. Unraveling the
function of those TH transporters during regeneration of
skeletal muscles might open additional therapeutic strate-
gies for AHDS patients.
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Animals
Mct8 KO mice were obtained from Deltagen and have been
described previously (Trajkovic et al., 2007). Oatp1c1 KO mice
were generated from Oatp1c1 fl/fl animals as reported before
(Mayerl et al., 2012). Breeding pairs were set up as depicted previ-
ously in order to obtain WT, Oatp1c1 KO, Mct8 KO, and Mct8/
Oatp1c1 DKO mice on a C57BL/6 background (Mayerl et al.,
2014).Mct8 KO andOatp1c1 KOmice were genotyped as described
previously (Mayerl et al., 2012; Trajkovic et al., 2007).
Conditional Mct8 mutant mice (C57BL/6 background) were
obtained from the KOMP repository (Slc16a2tm1a(KOMP)Wtsi).
Further information is provided in Supplemental Information.
Mct8 fl/flmice werematedwithOatp1c1 fl/flmice and transgenic
animals expressing a tamoxifen-inducible Cre recombinase driven
by the Pax7 promoter (Murphy et al., 2011). Detection of the
Pax7 CreERT2/+ transgene was performed as stated elsewhere
(Murphy et al., 2011). Mct8 fl/fl, Oatp1c1 fl/fl, Pax7-CreERT2 mice
were treated with tamoxifen to delete Mct8 and Oatp1c1 specif-
ically in SCs (M/O-SC KO) as described previously (von Maltzahn
et al., 2013).Mct8 fl/fl, Oatp1c1 fl/fl mice negative for the CreERT2
transgene and treated with tamoxifen served as controls. Genomic
DNA obtained from tail biopsies, brain, and gastrocnemiusmuscle
were subjected to PCR.
Mice were kept at constant temperature (22C) on a 12 hr light,
12 hr dark cycle and were provided with standard laboratory chow
and water ad libitum. Animals were sacrificed by cervical disloca-
tion at 2–4 months of age. Serum TH values were measured by
radioimmunoassay as published elsewhere (Friedrichsen et al.,
2003). For determination ofmuscle TH content and qPCR analysis,
TA muscles were rapidly frozen in liquid nitrogen. Muscle T4 and
T3 content was measured following rough homogenization and
extraction of the tissues as described in detail by Reyns et al.
(2002). Muscle tissues used for deiodinase activity assays were
processed as described before (Friedrichsen et al., 2003).
For regeneration experiments, TA muscles of female mice at the
age of 2.5–4 months were injured by intramuscular injection of
50 mL of CTX (10 mM in 0.9% NaCl) under isoflurane anesthesia
and isolated 5, 10, or 21 dpi. Muscles were cross sectioned
(12 mm) after embedding in cryoprotective medium (with 30% su-
crose), and frozen in liquid nitrogen.Affimetrix Microarray Data Acquisition
For cell-specific TH transporter expression analysis, we took advan-
tage of microarray data that have been published by Price et al.
(2014). In this study, quiescent SCs were isolated from heterozy-
gous Pax7-zsgreen mice after a 30 min collagenase/dispase diges-
tion and sorted for zsgreen expression (Price et al., 2014). The
Pax7-zsgreen mice express the zsgreen reporter under control of
the endogenous Pax7 promoter. In addition, Price et al. (2014)
sorted SCs from adultmice using alpha7 integrin in order to obtain
activated SCs that were consecutively cultured under proliferating
conditions (F10 medium with 20% FBS [Gibco] and 2.5 ng/mL
fibroblast growth factor [Gibco]) for obtainingmyoblasts, or under
differentiating conditions (DMEM with 5% horse serum [HS;
Gibco]) in order obtain myocytes (after 2 days in culture) andmyotubes (after 5 days in culture), respectively. Unfortunately,
activated SCs were not analyzed in this study.
Tissue Cultures
Single EDL myofibers were obtained from 2.5- to 4-month-old
mice and cultured for 0 hr, 42 hr, or 72 hr (Bentzinger et al.,
2013b). In brief, the EDL muscle was carefully removed, only
handling the tendons, and digested with 2.5 mL of collagenase I
(Sigma; final concentration, 0.2%) in DMEM for 45 min at 37C
under constant agitation. The muscle was then triturated using
Pasteur pipettes coated with HS until single fibers came off. Single
myofibers were transferred into culture medium (20% FBS in
DMEM, 1% chicken embryo extract [Seralab]) in a 24-well plate
coated with HS.
For inhibiting MCT8, Silychristin (25 mM, Sigma) was applied to
the culture medium of WT and Oatp1c1 KO-derived fiber cultures,
whereas control fibers received equal amounts of the solvent
(DMSO).
Immunofluorescence Studies
EDL myofibers were fixed with 2% paraformaldehyde (PFA) for
10 min, treated with 0.1 M glycine in PBS for 10 min, blocked,
and permeabilized with PBS containing 10% HS and 0.2% Triton
X-100. Subsequently, fibers were incubated with primary
antibodies in PBS overnight at 4C. Following washing with
0.2% Tween in PBS, fibers were incubated with fluorescence-
labeled secondary antibodies raised in goat (1:1,000, Alexa Fluor
488 or 555; Invitrogen) andwithHoechst 33258 (1:10,000) to label
cell nuclei. Thereafter, myofibers were washed, transferred on
Superfrost slides, mounted with Paramount, and analyzed using
an Olympus AX70 microscope.
Muscle cryosections (12 mm) were fixed with 2% PFA for 10 min,
permeabilizedwith 0.1%TritonX-100/0.1Mglycine, blockedwith
MOM reagent (1:40 in PBS, Vector laboratories), and incubated
with the respective primary antibody in PBS/5% goat serum
overnight at 4C. Subsequently, sections were incubated with
fluorescently Alexa Fluor 488- or 555-labeled secondary antibodies
(1:1,000) and Hoechst 33258 (1:10,000).
The following antibodies were used: rabbit anti-KI67 (1:500;
Sigma-Aldrich), rabbit anti-LAMININ (1:1,000; L9393, Sigma-
Aldrich), rabbit anti-MCT8 (1:500; HPA003353, Sigma-Aldrich),
mouse anti-fast MHC (1:500; M4276, Sigma-Aldrich), mouse
anti-slow MHC (1:500; M8421, Sigma-Aldrich), rabbit anti-
MYOD (1:250; sc-304, Santa Cruz Biotechnology), rabbit
anti-OATP1C1 (1:100; Mayerl et al., 2012), and mouse anti-PAX7
(undiluted; Developmental Studies HybridomaBank). TUNEL stain-
ingwas performedusing the In SituCellDeathDetectionKit (catalog
no.11684817910,Roche) following themanufacturer’s instructions.
qPCR
Detailed information on qPCR studies is provided in Supplemental
Information.
Quantification
In EDL fiber cultures, numbers of total MYOD-positive, MYOD-
only-positive, total PAX7-positive, PAX7-only-positive, and
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and soleus cross-sections were determined by staining 3–6 consec-
utive sections for LAMININ and the respectiveMHCantibodies. TA
muscle fiber diameter was assessed bymeasuring theminimal fiber
feret (defined as the minimum distance of parallel tangents at
opposing borders of the myofiber). For that purpose, whole
cross-sections of LAMININ stained muscles were analyzed with
an AxioObserver (Zeiss) utilizing the mosaic function provided
by the Zen software (Zeiss) to automatically stitch the images.
Quantification of fiber types was conductedmanually by counting
the number of slow and fast MHC-positive fibers and dividing
them by the number of total fibers in order to get the percentages
of slow and fast MHC-positive fibers per muscle respectively.
Following CTX injury, only those muscle fibers were included in
the analysis that displayed centrally located nuclei. Numbers of
MYOD-positive, PAX7-positive, and PAX7/MYOD double-positive
cells were counted per area.
Tamoxifen treatment efficiency was calculated by counting the
number of PAX7-positive cell clusters either showing or lacking
TH transporter immunofluorescent signals along 10 M/O-SC KO
EDL-derived myofibers 72 hr after isolation.
To quantify cell culture results, six to eight independent images
per sample and condition have been investigated. For proper
comparison between different samples and conditions, only
cross-sections of the muscle’s mid-belly regions were used in these
analyses, immunostainings were always performed in parallel, im-
ages were acquired with the same settings, and all measurements
were performed in a blinded manner.
Statistics
Values represent mean + SEM from at least three animals per geno-
type and time point. For multigroup comparisons, two-way
ANOVAwas performed (23 2 factorial ANOVA; factor A,WTversus
Oatp1c1 KO; factor B, WT versus Mct8 KO) using Daniels XL
Toolbox add-in for Microsoft Excel followed by Bonferroni-Holm
post hoc testing. Statistical significance between control and
M/O-SC KO mice was assessed by unpaired Student’s t test (Micro-
soft Excel). A p value less than 0.05 was considered significant.
Study Approval
All animal procedures were in accordance with the European
Union (EU) directive 2010/63/EU and approved by the Animal
Welfare Committee of the Thu¨ringer Landesamt fu¨r Lebensmittel-
sicherheit und Verbraucherschutz (03-011/14 and 03-48/16;
TLV; Bad Langensalza, Germany) and the Landesamt fu¨r Natur,
Umwelt und Verbraucherschutz Nordrhein-Westfalen (84-02-
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